抗药性症新生儿的性饮食:有效性和副作用 - - 一个中心的初步经验
Raffaele Falsaperla1,2, Vincenzo Sortino2,3, Ausilia Desiree Collotta2,3
1Neonatal Intensive Care Unit and Neonatal Accompaniment Unit, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco," San Marco Hospital, University of Catania, Catania, Italy.
Neuropediatrics
|June 15, 2023
概括
性饮食在新生儿重症监护室 (NICU) 治疗耐药的婴儿中显示出有效性. 仔细管理副作用对于优化这种性治疗至关重要.
科学领域:
- 儿科神经学 儿科神经学
- 代谢疗法 代谢疗法
- 新生儿护理 新生儿护理
背景情况:
- 婴儿的抗药性,特别是新生儿在NICU的治疗选择有限.
- 饮食是一种公认的治疗方法,但对非常年幼的婴儿的数据很少.
研究的目的:
- 评估基因饮食在患有耐药性的婴儿中短期 (3个月) 的有效性和安全性.
- 为了评估在NICU住院期间接受类饮食治疗的婴儿的结果.
主要方法:
- 对2个月以下的婴儿进行了回顾性研究,这些婴儿在治疗耐药性时采用了性饮食.
- 从2018年4月到2022年11月收集的NICU住院婴儿的数据.
主要成果:
- 在排除非响应者后,包括了10名婴儿;40%对类饮食有良好的反应.
- 由于副作用,四名患者停止了饮食,电解质,pH和胃肠道症状发生了显著变化.
- 在服用超过三种抗药物的婴儿中,观察到较高的尿和较低的血液pH值.
结论:
- 性饮食对患有的婴儿可能是有效和安全的.
- 对不良反应的早期和主动管理对于提高基因组治疗在这个人群中的安全性和有效性至关重要.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
218
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
218
Epilepsy and Seizures: Overview
230
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
Antiepileptic Drugs: GABAergic Pathway Potentiators
472
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
472
Antiepileptic Drugs: Sodium Channel Blockers
694
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
694
Antiepileptic Drugs: Calcium Channel Blockers
473
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
473
Antiepileptic Drugs: Glutamate Antagonists
435
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
435


